Matters pertaining to patent law
2026 · 2nd Quarter (Apr 1 - June 30)
GENEVANT SCIENCES, INC.
Filed by NOVEL STRATEGIES (FKA) PRISM GROUP.
Open official filingSource-reported fields
Filing overview
- Type
- Registration - Amendment
- Posted
- Aug 4, 2026
- Income
- Not reported
- Expenses
- Not reported
- Registrant
- NOVEL STRATEGIES (FKA) PRISM GROUP
- Client
- GENEVANT SCIENCES, INC.
- Filing UUID
- 5801301a-1074-4d87-b466-0e2a89ede2a3
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Matters pertaining to patent law
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.